We are live on ! Find out more
LFCR icon

Lifecore Biomedical
LFCR

124 hedge funds and large institutions have $301M invested in Lifecore Biomedical in 2013 Q2 according to their latest regulatory filings, with 124 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

86.36% more ownership

Funds ownership: 0% → 86.36% (+86%)

97% less call options, than puts

Call options by funds: $7K | Put options by funds: $267K

Holders
124
Holders Change
+124
Holders Change %
–
% of All Funds
4.03%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
124
Increased
–
Reduced
–
Closed
–
Calls
$7K
Puts
$267K
Net Calls
-$260K
Net Calls Change
-$260K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

LFCR Hedge Fund Activity: Q2 2013 in Review

124 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q2 2013, worth a combined $301M.

Buyers outnumbered sellers: 124 funds opened new LFCR positions and 0 closed out — a net gain of 124 holders — while 0 added to existing stakes and 0 trimmed.

  • 124 institutional investors held Lifecore Biomedical (LFCR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $301M of Lifecore Biomedical stock for Q2 2013.
  • 124 funds opened new Lifecore Biomedical positions in Q2 2013 and 0 closed out, a net change of +124 holders.

Based on aggregated 13F filings for Q2 2013.